Literature DB >> 14585602

Making connections: cholinesterase-domain proteins in the CNS.

Francisco G Scholl1, Peter Scheiffele.   

Abstract

Recent studies have highlighted novel functions of a group of cell adhesion molecules during nervous system development. Members of this protein family are characterized by an extracellular domain with sequence homology to cholinesterases and include the neuroligins, synaptic cell adhesion molecules recently implicated in autism, and neurotactin, a cell surface receptor involved in axonal pathfinding. Although these proteins have a structural organization similar to the enzyme acetylcholinesterase, the cholinesterase domain lacks enzymatic activity and functions as a protein-protein interaction motif. This protein family provides a striking example of how the function of a catalytically active domain has evolved to mediate receptor-ligand interactions that regulate morphogenetic processes during development of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14585602     DOI: 10.1016/j.tins.2003.09.004

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  16 in total

Review 1.  Processing of cholinesterase-like α/β-hydrolase fold proteins: alterations associated with congenital disorders.

Authors:  Antonella De Jaco; Davide Comoletti; Noga Dubi; Shelley Camp; Palmer Taylor
Journal:  Protein Pept Lett       Date:  2012-02       Impact factor: 1.890

Review 2.  Developmental biology of the enteric nervous system: pathogenesis of Hirschsprung's disease and other congenital dysmotilities.

Authors:  Michael D Gershon; Elyanne M Ratcliffe
Journal:  Semin Pediatr Surg       Date:  2004-11       Impact factor: 2.754

3.  Biophysical characterization of the unstructured cytoplasmic domain of the human neuronal adhesion protein neuroligin 3.

Authors:  Aviv Paz; Tzviya Zeev-Ben-Mordehai; Martin Lundqvist; Eilon Sherman; Efstratios Mylonas; Lev Weiner; Gilad Haran; Dmitri I Svergun; Frans A A Mulder; Joel L Sussman; Israel Silman
Journal:  Biophys J       Date:  2008-05-02       Impact factor: 4.033

4.  Neuroligin trafficking deficiencies arising from mutations in the alpha/beta-hydrolase fold protein family.

Authors:  Antonella De Jaco; Michael Z Lin; Noga Dubi; Davide Comoletti; Meghan T Miller; Shelley Camp; Mark Ellisman; Margaret T Butko; Roger Y Tsien; Palmer Taylor
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

5.  Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons.

Authors:  Haiheng Dong; Yun-Yan Xiang; Noa Farchi; William Ju; Yaojiong Wu; Liwen Chen; Yutian Wang; Binyamin Hochner; Burton Yang; Hermona Soreq; Wei-Yang Lu
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

6.  Aryl acylamidase activity on acetylcholinesterase is high during early chicken brain development.

Authors:  Rathanam Boopathy; Paul G Layer
Journal:  Protein J       Date:  2004-07       Impact factor: 2.371

Review 7.  Posttranslational Modifications Regulate the Postsynaptic Localization of PSD-95.

Authors:  Daniela Vallejo; Juan F Codocedo; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2016-02-16       Impact factor: 5.590

8.  Interaction of acetylcholinesterase with neurexin-1β regulates glutamatergic synaptic stability in hippocampal neurons.

Authors:  Yun-Yan Xiang; Haiheng Dong; Burton B Yang; John F Macdonald; Wei-Yang Lu
Journal:  Mol Brain       Date:  2014-03-05       Impact factor: 4.041

9.  Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer's Disease.

Authors:  Margarita C Dinamarca; Juvenal A Ríos; Nibaldo C Inestrosa
Journal:  Front Physiol       Date:  2012-12-20       Impact factor: 4.566

10.  Bridging the synaptic gap: neuroligins and neurexin I in Apis mellifera.

Authors:  Sunita Biswas; Robyn J Russell; Colin J Jackson; Maria Vidovic; Olga Ganeshina; John G Oakeshott; Charles Claudianos
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.